SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Healancy Biomedical
Healancy Biomedical Spółka z Ograniczoną Odpowiedzialnością
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Healancy Biomedical Spółka z Ograniczoną Odpowiedzialnością
Healancy Biomedical Spółka z Ograniczoną Odpowiedzialnością (KRS 0000348256, NIP 8992735311) is a Polish company, headquartered in Wrocław, Dolnośląskie voivodeship. HEALANCY BIOMEDICAL operates in: Other financial service activities, except insurance and pension funding, n.e.c. (PKD 64.99.Z). Industry: Finance and banking. The company has been listed in the National Court Register since February 5, 2010. HEALANCY BIOMEDICAL's most recently reported net revenue was 0 PLN for 2024.
Historical suspension of activities
Suspension: February 19, 2010 - resumed: July 9, 2012
Negative equity
Negative equity in 6 of 7 available reporting years.
No reported revenue
The company reported no revenue in any available reporting year. This may indicate a non-operating entity.
No arrears identified in the analyzed sources
No arrears or bankruptcy proceedings identified in the analyzed sources.
Main activity
64.99.ZOther financial service activities, except insurance and pension funding, n.e.c.
Other activities
General codes (divisions and groups)
General codes indicate a PKD division or group without a specific subclass.
Credibility rating
29.9 / 100
Poor credibility
Insolvency risk
Very low
Elevated threat
Closure risk
38
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
3
3/16 yrs
Board changes
5
5/16 yrs
PKD changes
2
2/16 yrs
Name changes
2
2/16 yrs
Data from 16 years of registry activity.
Payment reliability score from 2018–2024
Current: E (30/100)
Trend: improving (+4.0 pts/year)
Bardzo słaba wiarygodność płatnicza – współpraca handlowa wiąże się z wysokim ryzykiem braku zapłaty.
Standard limit from 2018–2024
Current: 0 PLN
Safe: 0 PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
February 5, 2010
16 years in operation
Legal form
SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Registry: RejP
Headquarters
WROCŁAW
DOLNOŚLĄSKIE
Primary PKD
64.99.Z
Other financial service activities, except insurance and pension fu…
Share capital
5.0 K PLN
Shareholders
2
shareholders
Board
1 person
Filed years
7 years
2018–2024 · profitable: 0/7
Registry entries
38
latest: January 15, 2026
Risk signals
Revenue
0 PLN
2024
Net profit
0 PLN
2024
Assets
1.9 K PLN
2024
Equity
-4.2 K PLN
2024
Valuation
1.0 K PLN
Low confidence
Low confidence
Rate business credibility - Healancy Biomedical.
No ratings

Explainer
BNP Paribas Bank Polska S.A. (KRS 0000011571), headquartered at ul. Marcina Kasprzaka 2 in Warsaw's Wola district, is a Polish bank controlled by France's BNP Paribas Group. The bank in its current form emerged from the merger of three historically separate entities: BGŻ (Bank Gospodarki Żywnościowej), Fortis Bank Polska, and Raiffeisen Polbank. Listed on the WSE since 2008, an mWIG40 constituent, with a seven-member management board and a twelve-member supervisory board.

News
Warsaw-based Bank Ochrony Środowiska S.A. (KRS 0000015525) - 58.05% controlled by NFOŚiGW - generated PLN 85.7 m net profit (+108.8% YoY) in Q1-Q3 2025. The balance sheet rose 9.8% to PLN 24.9 bn. The 2025-2027 strategy targets >PLN 30 bn in assets and a 50% share of green loans in the portfolio. The company has not paid a dividend since 2008 - all capital is reinvested in ESG lending.
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
HEALANCY BIOMEDICAL's board has 1 member.
Latest reporting year
2024
Available years
12
Filing entries
0
20 historical registry entries for Healancy Biomedical
Filing documents submitted (2 documents)
Board change, Shareholder change
WR.VI NS-REJ.KRS/23695/23/738
Board change
WR.VI NS-REJ.KRS/25624/23/232
Board change
WR.VI NS-REJ.KRS/38597/24/804
Filing documents submitted (4 documents)
Competing companies or those operating in the same market segment as Healancy Biomedical (in Wrocław, industry: Finance and banking).
WROCŁAW· Finance and banking
Revenue 2024: 161.5 M PLN
WROCŁAW· Finance and banking
Revenue 2024: 29.4 M PLN
WROCŁAW· Finance and banking
Revenue 2024: 28.0 M PLN
WROCŁAW· Finance and banking
Revenue 2024: 24.5 M PLN
WYSOKA· Finance and banking
Revenue 2024: 24.3 M PLN
WROCŁAW· Finance and banking
Revenue 2025: 14.8 M PLN